Huoling Shengji granule in amyotrophic lateral sclerosis: A multicenter, randomized, double-blind, riluzole-controlled trial.

Liu X, Fu W, Cui X, Feng Y, Wen B, Shan L, Xu X, Yang J, Zhang J, He L, Zang Y, Zhao S, Yao X, Liu Y, Ma M, Du B, Dang J, Zou Z, Feng H, Lu Z, Zhang Y, Wu Z, Shang H, Yin P, Fan D

Open source

DOI: 10.1016/j.neurot.2026.e00953
Published: 2026 Sep
Container: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.neurot.2026.e00953,
  title = {Huoling Shengji granule in amyotrophic lateral sclerosis: A multicenter, randomized, double-blind, riluzole-controlled trial.},
  author = {Liu X and Fu W and Cui X and Feng Y and Wen B and Shan L and Xu X and Yang J and Zhang J and He L and Zang Y and Zhao S and Yao X and Liu Y and Ma M and Du B and Dang J and Zou Z and Feng H and Lu Z and Zhang Y and Wu Z and Shang H and Yin P and Fan D},
  year = {2026},
  journal = {Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics},
  doi = {10.1016/j.neurot.2026.e00953},
  url = {https://doi.org/10.1016/j.neurot.2026.e00953}
}

RIS

TY  - JOUR
TI  - Huoling Shengji granule in amyotrophic lateral sclerosis: A multicenter, randomized, double-blind, riluzole-controlled trial.
AU  - Liu X
AU  - Fu W
AU  - Cui X
AU  - Feng Y
AU  - Wen B
AU  - Shan L
AU  - Xu X
AU  - Yang J
AU  - Zhang J
AU  - He L
AU  - Zang Y
AU  - Zhao S
AU  - Yao X
AU  - Liu Y
AU  - Ma M
AU  - Du B
AU  - Dang J
AU  - Zou Z
AU  - Feng H
AU  - Lu Z
AU  - Zhang Y
AU  - Wu Z
AU  - Shang H
AU  - Yin P
AU  - Fan D
PY  - 2026
JO  - Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
DO  - 10.1016/j.neurot.2026.e00953
UR  - https://doi.org/10.1016/j.neurot.2026.e00953
ER  -

APA

X, L., W, F., X, C., Y, F., B, W., L, S., X, X., J, Y., J, Z., L, H., Y, Z., S, Z., X, Y., Y, L., M, M., B, D., J, D., Z, Z., H, F., Z, L., Y, Z., Z, W., H, S., P, Y., & D, F. (2026). Huoling Shengji granule in amyotrophic lateral sclerosis: A multicenter, randomized, double-blind, riluzole-controlled trial.. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. https://doi.org/10.1016/j.neurot.2026.e00953

Source records

pubmed · retrieved 2026-09-26T03:52:52.535Z